Latest Health News

Monadelphous Group Limited has announced a fully franked ordinary dividend of AUD 0.39 per share for the half-year ending June 2025, alongside a Dividend Reinvestment Plan offering shareholders a flexible way to reinvest.

RWC reported a 5.5% increase in FY25 net sales driven by the Holman acquisition, while adjusted EBITDA edged up 1.1% amid margin pressures. The company warns of tariff-related cost impacts in FY26, offset by ongoing cost savings and strategic adjustments.

Simonds Group delivered stable FY25 revenue and modest EBITDA growth despite one-off acquisition expenses, positioning itself for growth through strategic product and channel expansion in FY26.

Universal Biosensors has extended the due diligence period with major investor Viburnum Funds as it continues to negotiate a secured loan facility, with no binding commitment yet reached.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

Apiam Animal Health has received a non-binding indicative proposal from Adamantem Capital Management to acquire the company at $0.88 per share, sparking a potential shift in ownership for the veterinary services leader.

Audinate reported a 33% revenue decline in FY25 due to OEM inventory adjustments but boosted gross margins to 82.1% through a software shift and completed the strategic Iris acquisition, setting the stage for growth in FY26.

GWA Group Limited has launched a $30 million on-market share buyback program, balancing capital return with ongoing investment in growth. The move underscores management's confidence in the company’s financial strength and outlook.

GWA Group Limited reported modest revenue and profit growth for FY2025, driven by disciplined execution amid challenging markets. The company raised its dividend and announced a $30 million on-market share buyback, underscoring confidence in its financial position.

Aurizon Holdings Limited has announced a fully franked ordinary dividend of AUD 0.065 per share for the six months ending June 2025, payable in September.

Fiducian Group Limited has reported a solid 23.5% rise in net profit for the 2025 financial year, alongside a 10.6% increase in revenue and a higher fully franked final dividend of 24.7 cents per share.